Neoadjuvant transarterial chemoembolization (TACE) plus PD-1 inhibitor bridging to tumor resection in intermediate-stage hepatocellular carcinoma patients

被引:0
|
作者
Caihua Zhu
Bing Dai
Hua Zhan
Ruoyu Deng
机构
[1] The Fourth People’s Hospital of Yueyang,Department of General Surgery
[2] Yueyang Traditional Chinese Medicine Hospital,Department of General Surgery
[3] Shanghai Jing’an District Central Hospital,Department of General Surgery
[4] Fudan University,School of Life Science
[5] University of Montpellier,Department of Health Management, Institute Montpellier Management
来源
关键词
Downstaging; Intermediate-stage hepatocellular carcinoma; Neoadjuvant therapy; Programmed cell death protein 1 inhibitor; Transarterial chemoembolization;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1065 / 1071
页数:6
相关论文
共 50 条
  • [1] Neoadjuvant transarterial chemoembolization (TACE) plus PD-1 inhibitor bridging to tumor resection in intermediate-stage hepatocellular carcinoma patients
    Zhu, Caihua
    Dai, Bing
    Zhan, Hua
    Deng, Ruoyu
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (03) : 1065 - 1071
  • [2] Transarterial chemoembolization plus a PD-1 inhibitor with or without lenvatinib for intermediate-stage hepatocellular carcinoma
    Xiang, Yan-Jun
    Wang, Kang
    Yu, Hong-Ming
    Li, Xiao-Wei
    Cheng, Yu-Qiang
    Wang, Wei-Jun
    Feng, Jin-Kai
    Bo, Meng-Han
    Qin, Ying-Yi
    Zheng, Yi-Tao
    Shan, Yun-Feng
    Zhou, Li-Ping
    Zhai, Jian
    Cheng, Shu-Qun
    [J]. HEPATOLOGY RESEARCH, 2022, 52 (08) : 721 - 729
  • [3] Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
    Kim, Jun Young
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    Choi, Gyu-Seong
    Saleh, Aldosri Meshal
    Joh, Jae-Won
    Cho, Sung Ki
    Shin, Sung Wook
    Carriere, Keumhee Chough
    Ahn, Joong Hyun
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2016, 22 (02) : 250 - 258
  • [4] Liver resection versus transarterial chemoembolization for the treatment of intermediate-stage hepatocellular carcinoma
    Chen, Shuling
    Jin, Huilin
    Dai, Zihao
    Wei, Mengchao
    Xiao, Han
    Su, Tianhong
    Li, Bin
    Liu, Xin
    Wang, Yu
    Li, Jiaping
    Shen, Shunli
    Zhou, Qi
    Peng, Baogang
    Peng, Zhenwei
    Peng, Sui
    [J]. CANCER MEDICINE, 2019, 8 (04): : 1530 - 1539
  • [5] Hepatic resection is superior to transarterial chemoembolization for treating intermediate-stage hepatocellular carcinoma
    Zhong, Jian-Hong
    Peng, Ning-Fu
    You, Xue-Mei
    Ma, Liang
    Li, Le-Qun
    [J]. LIVER INTERNATIONAL, 2017, 37 (07) : 1083 - 1084
  • [6] LIVER RESECTION VERSUS TRANSARTERIAL CHEMOEMBOLIZATION FOR THE TREATMENT OF INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA
    Zhu, Wanjie
    Chen, Shuling
    Jin, Huilin
    [J]. GUT, 2019, 68 : A128 - A128
  • [7] Transarterial chemoembolization plus camrelizumab is an effective and tolerable bridging therapy for patients with intermediate-stage hepatocellular carcinoma: A pilot study
    Huo, Haoran
    Wang, Xiaoying
    Xu, Shan
    Niu, Xiaotong
    Cheng, Limin
    Yuan, Zengjiang
    Huo, Shuang
    Fang, Pingping
    [J]. ONCOLOGY LETTERS, 2023, 26 (05)
  • [8] Hepatic Resection Versus Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: A Cohort Study
    Lu, Linbin
    Zheng, Peichan
    Wu, Zhixian
    Chen, Xiong
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] New intermediate-stage subclassification for patients with hepatocellular carcinoma treated with transarterial chemoembolization
    Kim, Jin Hyoung
    Shim, Ju Hyun
    Lee, Han Chu
    Sung, Kyu-Bo
    Ko, Heung-Kyu
    Ko, Gi-young
    Gwon, Dong Il
    Kim, Jong Woo
    Lim, Yung-Suk
    Park, Seong Ho
    [J]. LIVER INTERNATIONAL, 2017, 37 (12) : 1861 - 1868
  • [10] Efficacy of Sorafenib in Intermediate-Stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization
    Ogasawara, Sadahisa
    Chiba, Tetsuhiro
    Ooka, Yoshihiko
    Kanogawa, Naoya
    Motoyama, Tenyu
    Suzuki, Eiichiro
    Tawada, Akinobu
    Kanai, Fumihiko
    Yoshikawa, Masaharu
    Yokosuka, Osamu
    [J]. ONCOLOGY, 2014, 87 (06) : 330 - 341